vers la météo de la validation par utilisateur
+---------------------COMP:V_PASS-N(in)---------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:V_PASS-N(in) (associate,cholangiocarcinoma) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+-----COMP:V-N(in)----+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+COMP:N-N(of)+ +OBJ:V-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,cholangiocarcinoma)
+------------------------COMP:V-N(in)-----------------------+ | +--------COMP:N-N(of)-------+ | | | +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,cholangiocarcinoma) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+ +---------------COMP:N-N(of)--------------+ +-----COMP:V-N(in)----+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+ | +OBJ:V-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,cholangiocarcinoma)
+--------COMP:N-N(of)-------+ | +-MOD_ATT:N-ADJ+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+-COMP:N-N(in)-+ | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+--------COMP:N-N(of)-------+ | +-MOD_ATT:N-ADJ+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------COMP:N-N(in)---------------+ +--------COMP:N-N(of)-------+ | | +-MOD_ATT:N-ADJ+ | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,cholangiocarcinoma) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+--------COMP:N-N(of)-------+ | +-MOD_ATT:N-ADJ+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ | +MOD_AT+ | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+ +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+COMP:N-N(of)+ +OBJ:V-+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------COMP:N-N(in)---------------+ +--------COMP:N-N(of)-------+ | | +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,cholangiocarcinoma) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+--------COMP:N-N(of)-------+ | +-MOD_ATT:N-ADJ+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ | +MOD_AT+ | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+ +-------COMP:N-N(with)-------+ +-----COMP:V-N(in)----+ +--MOD_ATT:N-N--+SUBJ:V_PASS+ +COMP:N-N(of)+ +OBJ:V-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) SUBJ:V_PASS-N (associate,human) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,cholangiocarcinoma)
+---------------------SUBJ:V-N--------------------+ +---------------COMP:N-N(of)--------------+ | +--MOD_ATT:N-N--+SUBJ:V_PASS+COMP:V_PASS-N(wi+ | +OBJ:V-+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) COMP:V_PASS-N(with) (associate,upregulation) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+--------COMP:N-N(of)-------+ +--------SUBJ:V-N-------+ +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-ADJ-+ | +MOD_AT+ | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V-N (be,upregulation) MOD_ATT:N-ADJ (upregulation,associate) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+ +---------------COMP:N-N(of)--------------+ | +-------COMP:N-N(with)-------+ | +-----COMP:V-N(in)----+ +--MOD_ATT:N-N--+SUBJ:V_PASS+ | | +OBJ:V-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:V-N(in) (__NODE__,cholangiocarcinoma)
+--------COMP:N-N(of)-------+ +--------SUBJ:V-N-------+ +-MOD_ATT:N-ADJ+ | +--MOD_ATT:N-ADJ-+ | +MOD_AT+-COMP:N-N(in)-+ | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V-N (be,upregulation) MOD_ATT:N-ADJ (upregulation,associate) COMP:N-N(of) (upregulation,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------COMP:N-N(in)---------------+ +--------COMP:N-N(of)-------+ | +--------SUBJ:V-N-------+ +-MOD_ATT:N-ADJ+ | | +--MOD_ATT:N-ADJ-+ | +MOD_AT+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V-N (be,upregulation) MOD_ATT:N-ADJ (upregulation,associate) COMP:N-N(of) (upregulation,mRNA) COMP:N-N(in) (upregulation,cholangiocarcinoma) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------COMP:V_PASS-N(in)---------------------+ | +---------------OBJ:V-N--------------+ | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+COMP:N-N(of)+ +MOD_AT+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:V_PASS-N(in) (associate,cholangiocarcinoma) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+ +-------COMP:N-N(with)-------+ | +--MOD_ATT:N-N--+SUBJ:V_PASS+ +COMP:N-N(of)+ +OBJ:V-+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) SUBJ:V_PASS-N (associate,human) COMP:N-N(of) (upregulation,__SP__) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------------COMP:V_PASS-N(in)---------------------+ | +---------------OBJ:V-N--------------+ | | | +----COMP:N-N(of)----+ | | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ +MOD_ATT+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) COMP:V_PASS-N(in) (associate,cholangiocarcinoma) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)
+------------------------COMP:V-N(in)-----------------------+ | +---------------OBJ:V-N--------------+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,cholangiocarcinoma) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+------------------------COMP:V-N(in)-----------------------+ | +---------------OBJ:V-N--------------+ | | | +----COMP:N-N(of)----+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) COMP:V-N(in) (associate,cholangiocarcinoma) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)
+------------------------COMP:V-N(in)-----------------------+ +-------------------OBJ:V-N------------------+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,cholangiocarcinoma) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__)
+---------------------SUBJ:V-N--------------------+ +---------------COMP:N-N(of)--------------+ | +-------COMP:N-N(with)-------+ | | +--MOD_ATT:N-N--+SUBJ:V_PASS+ | | +OBJ:V-+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) COMP:N-N(with) (human,upregulation) COMP:N-N(of) (human,__SP__) SUBJ:V_PASS-N (associate,human) SUBJ:V-N (__NODE__,human) OBJ:V-N (__NODE__,mRNA) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+------------------------COMP:V-N(in)-----------------------+ +-------------------OBJ:V-N------------------+ | | +----COMP:N-N(of)----+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,cholangiocarcinoma) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__)
+---------------OBJ:V-N--------------+ +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+COMP:N-N(of)+ +MOD_AT+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------OBJ:V-N--------------+ | +----COMP:N-N(of)----+ | +-------SUBJ:V_PASS-N-------+COMP:V_PASS-N(wi+ +MOD_ATT+ +-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . SUBJ:V_PASS-N (associate,Cholangiocarcinoma) COMP:V_PASS-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------OBJ:V-N--------------+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+-COMP:N-N(in)-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+---------------OBJ:V-N--------------+ | +----COMP:N-N(of)----+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ +-COMP:N-N(in)-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (with,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+-------------------OBJ:V-N------------------+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +MOD_AT+-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:N-N(of) (upregulation,__SP__) MOD_ATT:N-ADJ (mRNA,__NODE__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+-------------------OBJ:V-N------------------+ | +----COMP:N-N(of)----+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+ +MOD_ATT+ +-COMP:N-N(in)-+ | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:N-N(of) (upregulation,__NODE__) MOD_ATT:N-ADJ (__NODE__,__SP__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+------------------------COMP:V-N(in)-----------------------+ +-------------------OBJ:V-N------------------+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,cholangiocarcinoma) COMP:N-N(of) (upregulation,__SP__)
+-------------------OBJ:V-N------------------+ +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ +-COMP:N-N(in)-+ | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:N-N(of) (upregulation,__SP__) COMP:N-N(in) (mRNA,cholangiocarcinoma)
+------------------------COMP:V-N(in)-----------------------+ +-------------------OBJ:V-N------------------+ | | +-----------OBJ:V-N-----------+ | | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | | | | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) COMP:V-N(in) (associate,cholangiocarcinoma) OBJ:V-N (with,__NODE__) COMP:N-N(of) (upregulation,__SP__)
+-------------------OBJ:V-N------------------+ | +-----------OBJ:V-N-----------+ | +--MOD_ATT:N-N--+--SUBJ:V-N-+-COMP:V-N(with)-+COMP:N-N(of)+ | +-COMP:N-N(in)-+ | | | | | | | | | Cholangiocarcinoma in humans is associated with upregulation of __SP__ __NODE__ mRNA in cholangiocarcinoma . MOD_ATT:N-N (human,Cholangiocarcinoma) SUBJ:V-N (associate,human) COMP:V-N(with) (associate,upregulation) OBJ:V-N (associate,mRNA) OBJ:V-N (with,__NODE__) COMP:N-N(of) (upregulation,__SP__) COMP:N-N(in) (mRNA,cholangiocarcinoma)